Table 1.
Interpretive criteria | Number of studies (% of 198 included*) |
---|---|
CLSI | 83 (41.9) |
Pre-2012 | 35 (17.7) |
2012 or later | 38 (19.2) |
Specific year unreferenced† | 10 (5.1) |
Not reported | 59 (29.8) |
The National Committee for Clinical Laboratory Standards (now CLSI as of 2005) | 47 (23.7) |
The European Committee on Antimicrobial Susceptibility Testing | 10 (5.1) |
The British Society for Antimicrobial Chemotherapy | 7 (3.5) |
The French Microbiology Society | 2 (1.0) |
Laboratory antimicrobial susceptibility testing method | |
Disc diffusion‡ | 173 (87.4) |
Minimum inhibitory concentration§ | 82 (41.4) |
Combination of at least two methods | 78 (39.4) |
Automated | 12 (6.1) |
Not reported | 9 (4.5) |
CLSI = Clinical and Laboratory Standards Institute.
Some studies used multiple interpretive criteria or testing strategies for different antimicrobials; thus, numbers will exceed the total number of studies included.
Two studies specified multiple CLSI years covering both pre-2012 and 2012 or later.
The Kirby–Bauer test and the Stokes method.
E-test, agar dilution, and broth dilution.